Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Design, synthesis, and biological investigation of selective human carbonic anhydrase II, IX, and XII inhibitors using 7-aryl/heteroaryl triazolopyrimidines bearing a sulfanilamide scaffold

R. Romagnoli, T. De Ventura, S. Manfredini, E. Baldini, CT. Supuran, A. Nocentini, A. Brancale, R. Bortolozzi, L. Manfreda, G. Viola

. 2023 ; 38 (1) : 2270180. [pub] 20231018

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24000410

A novel library of human carbonic anhydrase (hCA) inhibitors based on the 2-sulfanilamido[1,2,4]triazolo[1,5-a]pyrimidine skeleton modified at its 7-position was prepared by an efficient convergent procedure. These derivatives were evaluated in vitro for their inhibition properties against a representative panel of hCA isoforms (hCA I, II, IV, IX, and XII). The target tumour-associated isoforms hCA IX and XII were potently inhibited with KIs in the low nanomolar range of 5-96 nM and 4-72 nM, respectively. Compounds 1d, 1j, 1v, and 1x were the most potent hCA IX inhibitors with KIs of 5.1, 8.6, 4.7, and 5.1 nM, respectively. Along with derivatives 1d and 1j, compounds 1r and 1ab potently inhibited hCA XII isoform with KIs in a single-digit nanomolar range of 8.8, 5.4, 4.3, and 9.0 nM, respectively. Compounds 1e, 1m, and 1p exhibited the best selectivity against hCA IX and hCA XII isoforms over off-target hCA II, with selectivity indexes ranging from 5 to 14.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24000410
003      
CZ-PrNML
005      
20240213093149.0
007      
ta
008      
240109s2023 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1080/14756366.2023.2270180 $2 doi
035    __
$a (PubMed)37850364
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Romagnoli, Romeo $u Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Ferrara, Italy
245    10
$a Design, synthesis, and biological investigation of selective human carbonic anhydrase II, IX, and XII inhibitors using 7-aryl/heteroaryl triazolopyrimidines bearing a sulfanilamide scaffold / $c R. Romagnoli, T. De Ventura, S. Manfredini, E. Baldini, CT. Supuran, A. Nocentini, A. Brancale, R. Bortolozzi, L. Manfreda, G. Viola
520    9_
$a A novel library of human carbonic anhydrase (hCA) inhibitors based on the 2-sulfanilamido[1,2,4]triazolo[1,5-a]pyrimidine skeleton modified at its 7-position was prepared by an efficient convergent procedure. These derivatives were evaluated in vitro for their inhibition properties against a representative panel of hCA isoforms (hCA I, II, IV, IX, and XII). The target tumour-associated isoforms hCA IX and XII were potently inhibited with KIs in the low nanomolar range of 5-96 nM and 4-72 nM, respectively. Compounds 1d, 1j, 1v, and 1x were the most potent hCA IX inhibitors with KIs of 5.1, 8.6, 4.7, and 5.1 nM, respectively. Along with derivatives 1d and 1j, compounds 1r and 1ab potently inhibited hCA XII isoform with KIs in a single-digit nanomolar range of 8.8, 5.4, 4.3, and 9.0 nM, respectively. Compounds 1e, 1m, and 1p exhibited the best selectivity against hCA IX and hCA XII isoforms over off-target hCA II, with selectivity indexes ranging from 5 to 14.
650    _2
$a lidé $7 D006801
650    12
$a karboanhydrasa II $x metabolismus $7 D024402
650    _2
$a vztahy mezi strukturou a aktivitou $7 D013329
650    _2
$a karboanhydrasa IX $x metabolismus $7 D000071231
650    12
$a antigeny nádorové $7 D000951
650    _2
$a karboanhydrasa I $x metabolismus $7 D024401
650    _2
$a protein - isoformy $7 D020033
650    _2
$a sulfanilamidy $7 D013424
650    _2
$a inhibitory karboanhydras $x farmakologie $7 D002257
650    _2
$a molekulární struktura $7 D015394
655    _2
$a časopisecké články $7 D016428
700    1_
$a De Ventura, Tiziano $u Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Ferrara, Italy
700    1_
$a Manfredini, Stefano $u Department of Life Sciences and Biotechnology, University of Ferrara, Ferrara, Italy
700    1_
$a Baldini, Erika $u Department of Life Sciences and Biotechnology, University of Ferrara, Ferrara, Italy
700    1_
$a Supuran, Claudiu T $u Department of NEUROFARBA, Section of Pharmaceutical and Nutraceutical Sciences, University of Florence, Florence, Italy $1 https://orcid.org/0000000342620323 $7 ntk20191052919
700    1_
$a Nocentini, Alessio $u Department of NEUROFARBA, Section of Pharmaceutical and Nutraceutical Sciences, University of Florence, Florence, Italy
700    1_
$a Brancale, Andrea $u Vysoká Škola Chemicko-Technologická v Praze, Prague, Czech Republic
700    1_
$a Bortolozzi, Roberta $u Department of Woman's and Child's Health, Hemato-Oncology Lab, University of Padova, Padova, Italy $u Department of Pharmaceutical and Pharmacological Sciences, Section of Pharmacology, University of Padova, Padova, Italy $u Laboratory of Experimental Pharmacology, Istituto di Ricerca Pediatrica (IRP), Padova, Italy
700    1_
$a Manfreda, Lorenzo $u Department of Woman's and Child's Health, Hemato-Oncology Lab, University of Padova, Padova, Italy $u Laboratory of Experimental Pharmacology, Istituto di Ricerca Pediatrica (IRP), Padova, Italy
700    1_
$a Viola, Giampietro $u Department of Woman's and Child's Health, Hemato-Oncology Lab, University of Padova, Padova, Italy $u Laboratory of Experimental Pharmacology, Istituto di Ricerca Pediatrica (IRP), Padova, Italy $1 https://orcid.org/000000019329165X
773    0_
$w MED00008009 $t Journal of enzyme inhibition and medicinal chemistry $x 1475-6374 $g Roč. 38, č. 1 (2023), s. 2270180
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37850364 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240109 $b ABA008
991    __
$a 20240213093147 $b ABA008
999    __
$a ok $b bmc $g 2049210 $s 1210104
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 38 $c 1 $d 2270180 $e 20231018 $i 1475-6374 $m Journal of enzyme inhibition and medicinal chemistry $n J Enzyme Inhib Med Chem $x MED00008009
LZP    __
$a Pubmed-20240109

Najít záznam

Citační ukazatele

Možnosti archivace